Paediatrics in Berlin

European Respiratory Journal

Volumn 34, Issue 2, 2008, Pages 436-443

  Barbato, A ^a   Bertuola, F ^a   Kuehni, C ^b   Korppi, M ^c   Kotecha, S ^d   Pijnenburg, M W ^g   Ratjen, F ^h   Seddon, P ^e   Bush, A ^f  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e ALEXANDRA HOSPITAL   (United Kingdom)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Asthma; Cystic fibrosis; Intensive care; Lung function; Primary ciliary dyskinesia; Respiratory infection

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 8; NITRIC OXIDE; POLYUNSATURATED FATTY ACID; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANTIBIOTIC THERAPY; ASTHMA; BRONCHOSCOPY; CILIARY DYSKINESIA; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE CONTROL; DISEASE EXACERBATION; EXPIRED AIR; FORCED EXPIRATORY VOLUME; GERMANY; HUMAN; INTENSIVE CARE; LUNG FUNCTION TEST; LUNG LAVAGE; MEDICAL LITERATURE; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SCREENING TEST; SENSITIZATION; TECHNIQUE; WHEEZING;

ASTHMA; CHILD; CYSTIC FIBROSIS; EUROPE; GERMANY; HUMANS; HYPERSENSITIVITY; PEDIATRICS; PULMONARY MEDICINE; RESPIRATORY SYSTEM;

EID: 69249116232     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00038809     Document Type: Review

References (121)

1. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110.
2. Schultz A, Devadason S, Olga S, et al. Reliability of clinical classifications of wheezing in preschool children. Eur Respir J 2008; 32: Suppl. 52, 284s.
3. Moeller A, Luchsinger I, Knauer N, et al. Exhaled nitric oxide is elevated in young preschool children with persistent asthma at school age. Eur Respir J 2008; 32: Suppl. 52, 284s.
4. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998-2005.
5. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk of asthma. N Engl J Med 2006; 354: 1985-1997.
6. Murray CS, Woodcock A, Langley SJ, et al. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368: 754-762.
7. Kamenov A, Cekic S. Prevalence of sensitization to aeroallergens in preschool children <5 yrs of age with symptoms of atopic disease. Eur Respir J 2008; 32: Suppl. 52, 701s.
8. Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368: 763-770.
9. Kamenov S, Moskovljevic J, Kamenov B. Asthma chronicity in school children determines continuing allergic inflammation. Eur Respir J 2008; 32: Suppl. 52, 803s.
10. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162: 2341-2351.
11. Bush A Hedlin G, Carlsen K, et al. Severe childhood asthma: a common international approach? Lancet 2008; 372: 1019-1021.
12. Hall P, Bracken M, Biggart E, et al. Results of nurse led home visits for children with difficult asthma. Eur Respir J 2008; 32: Suppl. 52, 803s.
13. Bossley C, Kavanagh C, Tsartsalli L, et al. Characeristics of paediatric difficult asthma and systemic corticosteroid responsiveness. Eur Respir J 2008; 32: Suppl. 52, 696s.
14. Lex C, Fleming L, Bossley C, et al. Corticosteroid sensitivity, persistent airflow limitation and basement membrane thickening in children with asthma. Eur Respir J 2008; 32: Suppl. 52, 802s.
15. GINA Report. Global Strategy for Asthma Management and Prevention. From the Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2006. Available from: www.ginasthma.org
16. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5-34.
17. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol 2007; 120: S94-S138.
18. Saito J, Inokoshi Y, Dsaito K, et al. Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control. Eur Respir J 2008; 32: Suppl. 52, 771s.
19. Tsartsali L, Regamey N, Bossley C, et al. Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma. Eur Respir J 2008; 32: Suppl. 52, 694s.
20. Ben-Ari J, Weiss-Kasirer T, Sprecher E, et al. Ambulatory monitoring of exhaled nitric oxide in childhood asthma exacerbation. Eur Respir J 2008; 32: Suppl. 52, 694s.
21. Robroeks C, Jobsis Q, Braekers R, et al. Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate. Eur Respir J 2008; 32: Suppl. 52, 694s.
22. Khetsuriani N, Lu X, Teague WG, et al. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis 2008; 14: 1793-1796.
23. Bizzintino J, Lee W, Laing I, et al. Rhinovirus infection in acute asthma in children presenting to an emergency room. Eur Respir J 2008; 32: Suppl. 52, 705s.
24. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61: 376-382.
25. Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357: 1487-1495.
26. Kozlowska WJ, Bush A, Wade A, et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 42-49.
27. Davis SD, Ratjen F. Reduced lung function in cystic fibrosis: a primary or secondary phenotype?Am J Respir Crit Care Med 2008; 178: 2-3.
28. Linnane BM, Hall GL, Nolan G, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178: 1238-1244.
29. Nolan G, Brennan S, Sly PD, et al. Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life. Eur Respir J 2008; 32: Suppl. 52, 515s.
30. Pillarisetti N, Linnane B, Hall GL, et al. Longitudinal changes in lung function and the association with pulmonary structure and infection in infants with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 539s.
31. Loeve M, Lequin M, de Bruijne M, et al. Measuring trapped air by computed tomography (CT) in CF: in search of the optimal protocol. Eur Respir J 2008; 32: Suppl. 52, 540s.
32. Bakker M, Borsboom G, Tiddens H. CF lung disease starts in the peripheral airways. Does it? Eur Respir J 2008; 32: Suppl. 52, 502s.
33. Horsley A, Macleod K, Bell N, et al. Scond is an early and sensitive measure of airways dysfunction in CF. Eur Respir J 2008; 32: Suppl. 52, 540s.
34. Hatziagorou E, Kirvassilis F, Tsanakas J. Comparison of lung function tests in preschoolers with cystic fibrosis and healthy subjects. Eur Respir J 2008; 32: Suppl. 52, 302s.
35. Oliver C, Stanojevic S, Wade A, et al. Longitudinal changes in lung clearance index in cystic fibrosis and health from preschool to school age. Eur Respir J 2008; 32: Suppl. 52, 514s.
36. Macleod K, Dhouieb E, Riding K, et al. Acute changes in ventilation heterogeneity following routine physiotherapy in children with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 690s.
37. Fuchs S, Toussaint S, Edlhaimb B, et al. Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF). Eur Respir J 2008; 32: Suppl. 52, 690s.
38. De Boeck K, Vermeulen F, Vreys M, et al. Airway clearance techniques to treat acute respiratory disorders in previously healthy children: where is the evidence? Eur J Pediatr 2008; 167: 607-612.
39. Scrase E, Oliver C, Kozlowska W, et al. Change in lung clearance index (LCI) following intravenous antibiotic intervention in children with CF. Eur Respir J 2008; 32: Suppl. 52, 514s.
40. Keen C, Olin AC, Eriksson S, et al. Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 541s.
41. de Winter-de Groot KM, van Haren Noman S, Slieker MG, et al. Association between nitric oxide and clinical phenotype in children with CF. Eur Respir J 2008; 32: Suppl. 52, 505s.
42. Robroeks C, Jobsis R, Braeckers R, et al. Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate. Eur Respir J 2008; 32: Suppl. 52, 540s.
43. Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18: 347-361.
44. Khalilzadeh S, Boloursaz MR, Kodayari A, et al. Inheritable disoirders of interferon-γ-IL-12 pathway: diagnosis and management. Eur Respir J 2008; 32: Suppl. 52, 482s.
45. Boukari R, Smati L, Benhalla NK, et al. Pulmonary disease in primary immunodeficiennies in children: report of 61 cases. Eur Respir J 2008; 32: Suppl. 52, 483s.
46. Dmenska H, Heropolitanska E, Pietrucha B, et al. Pulmonary manifestations of hyper-IgE syndromes. Eur Respir J 2008; 32: Suppl. 52, 484s.
47. Ballow M. Approach to the patient with recurrent infections. Review. Clin Rev Allergy Immunol 2008; 34: Suppl. 52, 129-140.
48. Fazekas T, Lawitschka A, Attarbaschi A, et al. Late pulmonary complications after haematopoetic stem cell transplantation in children: incidence and risk factors. Eur Respir J 2008; 32: Suppl. 52, 483s-484s.
49. Korppi M, Hiltunen J. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2007; 26: 316-318.
50. Robles-Cascallar P, Sanz-Moreno JC, Fidalgo-Marron L, et al. Whooping cough in school age children with persistent cough in Madrid. Eur Respir J 2008; 32: Suppl. 52, 483s.
51. Kavaliunaite E, Nackerviciute I. Bordetella pertussis infection in infants with prolonged cough. Eur Respir J 2008; 32: Suppl. 52, 482s-483s.
52. Bamberger ES, Srugo I. What is new in pertussis? Review. Eur J Pediatr 2008; 167: 133-139.
53. Chang AB, Redding GJ, Everard ML. Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Review. Pediatr Pulmonol 2008; 43: 519-531.
54. Abid H, Bachouch I, Ammar J, et al. Are there predictive factors for bronchiectasis in children with recurrent lower respiratory tract infections? Eur Respir J 2008; 32: Suppl. 52, 246s.
55. Tsang KW, Lam SK, Lam WK, et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 1998; 158: 1047-1051.
56. Angrill J, Sánchez N, Agustí C, et al. Does Helicobacter pylori have a pathogenic role in bronchiectasis? Respir Med 2006; 100: 1202-1207.
57. Ilvan A, Ozturkeri H, Capraz F, et al. Investigation of Helicobacter pylori in bronchoscopic lung specimens of young male patients with bronchiectasis but without gastrointestinal symptoms. Clin Microbiol Infect 2004; 10: 257-260.
58. Teke TA, Yilmaz YA, Yalcin E, et al. Is there any role of Helocobacter pylori in the pathogenesis of bronchiectasia? Eur Respir J 2008; 32: Suppl. 52, 247s.
59. Eickhoff P, Fazekas T, Pruckner R, et al. Recurrent episodes of lung infections in the first month of life - don't forget Scimitar syndrome. Eur Respir J 2008; 32: Suppl. 52, 708s.
60. Lange J, Talarek E, Krenke K. Pulmonary echinoccosis mimicking lung abscess in a 11-year old boy. Eur Respir J 2008; 32: Suppl. 52, 709s.
61. Stocks J, Coates A, Bush A. Lung function in infants and young children with chronic lung disease of infancy: the next steps? Pediatr Pulmonol 2007; 42: 3-9.
62. Prendergast M, Nicolaides K, Rafferty G, et al. Infants with surgically correctable anomalies: relationship of 3-D fetal lung volumes to neonatal respiratory outcomes. Eur Respir J 2008; 32: Suppl. 52, 806s.
63. Zannin E, Ventura ML, Furlan F, et al. Measurement of total and compartmental chest wall volume changes in newborns by optoelectronic plethysmography (OEP). Eur Respir J 2008; 32: Suppl. 52, 806s.
64. Shearman A, Hough J, Schibler A. Measurement of ventilation distribution in infants with congenital diaphragmatic hernia. Eur Respir J 2008; 32: Suppl. 52, 807s.
65. Schibler A, Frey U. Role of lung function testing in the management of mechanically ventilated infants. Arch Dis Child 2002; 87: F7-F10.
66. Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment. Arch Dis Child 1995; 72: F14-F19.
67. Pauliks LB, Vogel M, Mädler CF, et al. Regional response of myocardial acceleration during isovolumic contraction during dobutamine stress echocardiography: a color tissue Doppler study and comparison with angiocardiographic findings. Echocardiography 2005; 22: 797-808.
68. Joshi S, Edwards JM, Wilson DW, et al. Preterm infants have subclinically reduced myocardial function compared with healthy term controls. Eur Respir J 2008; 32: Suppl. 52, 812s.
69. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 219-226.
70. Vrijlandt EJ, Gerritsen J, Boezen HM, et al. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med 2006; 173: 890-896.
71. Vrijlandt E, Kerstjens J, Duiverman E, et al. Late preterms suffer from more respiratory problems than healthy children. Eur Respir J 2008; 32: Suppl. 52, 807s.
72. Filippone M, Sartor M, Zacchello F, et al. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 2003; 361: 753-754.
73. Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 1259-1265.
74. Ionescu AA, Ionescu AA, Payne N, et al. Subclinical right ventricular dysfunction in cystic fibrosis. A study using tissue Doppler echocardiography. Am J Respir Crit Care Med 2001; 163: 1212-1218.
75. Barker DJ, Osmond C. Low birth weight and hypertension. BMJ 1988; 297: 134-135.
76. Bolton CE, Cockcroft JR, Fawke J, et al. Arterial stiffness in relation to lung function in children aged 11 years born extremely preterm. Eur Respir J 2008; 32: Suppl. 52, 513s.
77. 6 and He washout. Eur Respir J 2003; 21: 1033-1039.
78. Aurora P, Gustafsson PM, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004; 59: 1068-1073.
79. Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 249-256.
80. Fuchs S, Gappa M. Multiple breath washout (MBW): within-test repeatability and short-term reproducibility of FRC and lung clearance index (LCI) in healthy children and adolescents. Eur Respir J 2008; 32: Suppl. 52, 300s.
81. Macleod K, Horsley A, Latzin P, et al. Modifications to a photoacoustic gas analyser increases accuracy of functional residual capacity measurements by multiple breath washout of SF6 in an infant lung model. Eur Respir J 2008; 32: Suppl. 52, 691s.
82. Hatziagorou E, Kirvassilis F, Tsanakis J. Comparison of lung function tests in preschoolers with cystic fibrosis and healthy subjects. Eur Respir J 2008; 32: Suppl. 52, 302s.
83. Latzin P, Thamrin C, Kyburz M, et al. Reference values of lung function measurements in healthy infants. Eur Respir J 2008; 32: Suppl. 52, 689s.
84. Hutten GJ, van Eykern LA, Latzin P, et al. Altered interaction of respiratory muscle activity, flow and lung volume in infants with chronic lung disease compared to healthy controls. Eur Respir J 2008; 32: Suppl. 52, 513s.
85. Foster K, Pham T, Schibler A. Regional ventilation distribution in healthy newborns. Eur Respir J 2008; 32: Suppl. 52, 514s.
86. Olden C, Savage E, Wertheim D, et al. Respiratory data from frequency analysis of pulse oximeter plethysmogram traces in newborn infants. Eur Respir J 2008; 32: Suppl. 52, 692s.
87. Midulla F, de Blic J, Barbato A, et al. Flexible endoscopy of paediatric airways. Eur Respir J 2003; 22: 698-708.
88. de Blic J, Marchac V, Scheinmann P. Complications of flexible bronchoscopy in children: prospective study of 1,328 procedures. Eur Respir J 2002; 20: 1271-1276.
89. Galbova S, Dimceva B, Obocki K, et al. Bronchological findings in childrenwith persistent stridor. Eur Respir J 2008; 32: Suppl. 52, 219s.
90. Provoost E, de Winter-deGroot KM, Arets HGM, et al. Tracheobronchial foreign body aspiration in childhood: an analysis of 119 cases. Eur Respir J 2008; 32: Suppl. 52, 218s.
91. Pekcan S, Kose M, Cobanoglu N, et al. Primary endobronchial leiomyoma in children. Eur Respir J 2008; 32: Suppl. 52, 219s.
92. Galbova S, Dimceva B, Manceva B, et al. The role of bronchoscopy in children with atelectasis. Eur Respir J 2008; 32: Suppl. 52, 5s.
93. Kovacs L. Bronchological examinations in the neonatal intensive care unit. Eur Respir J 2008; 32: Suppl. 52, 5s.
94. Banac S, Ahel V, Rozmanic V, et al. Primary bronchomalacia successfully treated with bronchopexy. Eur Respir J 2008; 32: Suppl. 52, 6s.
95. Flores-Hernandez SS, Gonzalez-Flores ML. Plastic bronchitis. A case report. Eur Respir J 2008; 32: Suppl. 52, 219s.
96. Kim YH, Choi SM, Hyun MC. Plastic bronchitis in childhood - case report. Eur Respir J 2008; 32: Suppl. 52, 220s.
97. Baraldo S, Turato G, Bazzan E, et al. Structural alterations in childhood asthma are not dependent on eosinophilic inflammation. Eur Respir J 2008; 32: Suppl. 52, 337s.
98. Lex C, Ferreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006; 174: 1286-1291.
99. Snijders D, Dalla Via P, Michelin E, et al. Inflammatory mediators in the BAL of children in relation to asthma and atopy. Eur Respir J 2008; 32: Suppl. 52, 5s.
100. Pires NF, Morais A, Azevedo I, et al. Bronchoalveolar lavage in children with diffuse lung disease. Eur Respir J 2008; 32: Suppl. 52, 219s.
101. Sias S, Daltro P, Marchiori E, et al. Multiple bronchoalveolar lavage as an important tool for treating lipoid pneumonia associated with ascariasis. Eur Respir J 2008; 32: Suppl. 52, 5s.
102. Provoost E, de Winter-de Groot KM, Arets HGM, et al. Tracheobronchial foreign body aspiration in childhood: an analysis of 119 cases. Eur Respir J 2008; 32: Suppl. 52, 218s.
103. Turner S, Campbell D, Smith N, et al. Fetal crown-rump length at ten weeks gestation is an independent predictor of lung function aged five years. Eur Respir J 2008; 32: Suppl. 52, 771s.
104. Turner S, Campbell D, Smith N, et al. Transient asthma symptoms are associated with reduced fetal measurements at ten and twenty weeks gestation. Eur Respir J 2008; 32: Suppl. 52, 563s.
105. Granell R, Cookson H, Henderson J. Maternal anxiety during pregnancy is associated with asthma in their offspring. Eur Respir J 2008; 32: Suppl. 52, 772s.
106. Latzin P, Röösli M, Huss A, et al. Air pollution in pregnancy and lung function in newborns: a birth cohort study. Eur Respir J 2008; 32: Suppl. 52, 773s.
107. Rochat M, Plabst D, Ege M, et al. Cord blood expression of ILT3 and ILT4 and its relation to prenatal farm exposure. Eur Respir J 2008; 32: Suppl. 52, 772s.
108. Ege M, Herzum I, Büchele G, et al. Prenatal exposure to a farm environment affects atopic sensitization at birth. Eur Respir J 2008; 32: Suppl. 52, 563s.
109. Illi S, Strunz-Lehner C, Zutavern A, et al. Environmental factors in early life and atopy in an urban birth cohort up to age 5 years. Eur Respir J 2008; 32: Suppl. 52, 772s.
110. Caudri D, Wijga A, Smit J, et al. Early daycare: more infections and asthma symptoms in infancy, no prevention of (allergic) asthma at 8 years. Eur Respir J 2008; 32: Suppl. 52, 772s.
111. Strippoli M, Spycher B, Silverman M, et al. Breastfeeding and the risk of childhood asthma: a population-based cohort study. Eur Respir J 2008; 32: Suppl. 52, 772s.
112. Spycher B, Silverman M, Strippoli M, et al. Predicting persistence of childhood wheeze using a symptom based severity score. Eur Respir J 2008; 32: Suppl. 52, 562s-563s.
113. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758-764.
114. O'Callaghan C, Chilvers M, Hogg C, et al. Diagnosing primary ciliary dyskinesia. Thorax 2007; 62: 656-657.
115. Bush A, Chodhari R, Collins N, et al. Primary ciliary dyskinesia: current state of the art. Arch Dis Child 2007; 92: 1136-1140.
116. Coren ME, Meeks M, Morrison I, et al. Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr 2002; 91: 667-669.
117. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004; 169: 459-467.
118. Scigliano S, Maffey A, Lopez M, et al. Primary ciliary dyskinesia: phenotypic features of a cohort of patients in Argentina. Eur Respir J 2008; 32: Suppl. 52, 714s.
119. Maurer E, Barbato A, Frischer T, et al. Treatment of primary ciliary dyskinesia (PCD) in children across Europe. Eur Respir J 2008; 32: Suppl. 52, 714s.
120. Strippoli M, Frischer T, Barbato A, et al. Age at diagnosis in children with primary ciliary dyskinesia (PCD) across Europe. Eur Respir J 2008; 32: Suppl. 52, 714s.
121. Yiallouros P, Aristodemou S, Bartsota M, et al. Primary ciliary dyskinesia epidemiology in Cyprus. Eur Respir J 2008; 32: Suppl. 52, 713s-714s.